Trial intelligence / Profile preview

Inhaled Sodium Nitrite for Pseudomonas in Cystic Fibrosis

NCT02694393Phase 2Terminated

Start
Feb 2016
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium nitrite in cystic fibrosis (CF). Started Feb 2016; status: terminated.

02

Drugs

sodium nitrite
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT02694393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02694393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call